Henry Ford Hospital Hematology and Medical Oncology

Topics

• CAR-T cell therapy research 57
• Glioma Diagnosis and Treatment 49
• Lymphoma Diagnosis and Treatment 45
• Prostate Cancer Treatment and Research 38
• Chronic Lymphocytic Leukemia Research 32
• Hematopoietic Stem Cell Transplantation 24
• Cancer Immunotherapy and Biomarkers 22
• Palliative Care and End-of-Life Issues 21
• Acute Myeloid Leukemia Research 18
• Pancreatic and Hepatic Oncology Research 18
• Lung Cancer Treatments and Mutations 17
• COVID-19 and healthcare impacts 16

Most cited

1. Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma.

   The New England journal of medicine · 2022 · 1,350 citations · Javier Munoz

2. Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial.

   The Lancet. Oncology · 2022 · 573 citations · Javier Munoz

3. Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial.

   JAMA oncology · 2023 · 399 citations · Tobias Walbert

4. Five-year follow-up of ZUMA-1 supports the curative potential of axicabtagene ciloleucel in refractory large B-cell lymphoma.

   Blood · 2023 · 409 citations · Javier Munoz

5. Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 292 citations · Javier Munoz

6. ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025 · 90 citations ·